Development of Hematopoietic Cancers After Implantation of Total Joint Replacement
- 1 August 1996
- journal article
- Published by Wolters Kluwer Health
- Vol. 329, S290-S296
- https://doi.org/10.1097/00003086-199608001-00026
Abstract
The evidence from the 4 epidemiologic studies published before mid 1995, which have investigated the incidence of cancers in patients who have undergone joint implants, is conflicting. The results of the 2 earlier studies suggested a sustained increase in the risk of lymphoma and leukemia after total hip arthroplasty. The results of the 2 more recent studies have not confirmed this, although in 1 study an increased risk was observed in the first year after implantation. The heterogeneity may be statistical in origin, but could also have a biologic explanation in the greater proportion of metal on metal prostheses used before 1973. All 4 studies used national data as the comparison. Here, are presented the results of 2 matched cohort studies and a case control study set in North America and Scotland, and an overview of the 4 previous studies. Neither the results of the matched studies of patients operated on after 1973 nor the results of the latter 2 published studies suggest an increased risk of lymphoma or leukemia. If metal on metal articulations are reintroduced, careful surveillance is essential.Keywords
This publication has 5 references indexed in Scilit:
- Total hip replacement and cancer. A cohort studyThe Journal of Bone and Joint Surgery. British volume, 1995
- Cancer Risk After Hip Replacement With Metal Implants: a Population-Based Cohort Study in SwedenJNCI Journal of the National Cancer Institute, 1995
- Estrogens, Progesterone, and Endometrial CancerEpidemiology, 1993
- The incidence of cancer following total hip replacementThe Journal of Bone and Joint Surgery. British volume, 1988
- Postmarketing Follow‐up at Group Health Cooperative of Puget SoundPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1984